drugset / Trial / NCT03340870

A Study to Evaluate Pharmacokinetics of Sonazoid™ Following Intravenous Bolus Injection in Healthy Volunteers

NCT03340870

Phase 1 Completed 16 enrolled GE Healthcare
Non-randomizedParallel-groupOpen-labelOther

Summary

The primary purpose of this study is to determine the Pharmacokinetics (PK) data of perfluorobutane (PFB) in blood and exhaled air following intravenous (I.V.) bolus injection of Sonazoid™ in healthy volunteers.

Timeline

Start
2014-10-20
Primary completion
2014-11-20
Completion
2014-11-20

Drugs

EvaluationDrugModalityDoseRoute
Subject Perflubutane Diagnostic / imaging agent 0.12 unknown Intravenous
Subject Perflubutane Diagnostic / imaging agent 0.6 unknown Intravenous

Indications

No indication recorded.